Table 2. Age-standardized lymphoid leukemia and lymphoma incidence rates (per million person-years) in children and adolescents in Manitoba, Canada: 1984–2013.
| Classification | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
| 0–14 years | 0–19 years | 0–14 years | 0–19 years | |||||
| N | Rate (95% CI) | N | Rate (95% CI) | N | Rate (95% CI) | N | Rate (95% CI) | |
| Lymphoid leukemia | 155 | 41.5 (34.9–48.0) |
171 | 34.0 (28.9–39.1) |
117 | 32.9 (25.9–38.9) |
125 | 26.2 (21.5–30.7) |
| Hodgkin lymphoma | 19 | 5.1 (2.8–7.4) |
53 | 10.5 (7.7–13.3) |
13 | 3.7 (1.7–5.6) |
60 | 12.5 (9.4–15.7) |
| Non-Hodgkin lymphoma (overall) | 40 | 10.7 (7.4–14.0) |
63 | 12.5 (9.3–15.4) |
23 | 6.5 (3.8–9.1) |
37 | 7.7 (5.2–10.2) |
| Non-Hodgkin lymphoma (except Burkitt lymphomas) | 27 | 7.2 (4.5–9.9) |
47 | 9.3 (6.7–12.0) |
17 | 4.8 (2.5–7.1) |
30 | 6.3 (4.0–8.5) |
| Precursor cell lymphomas | 11 | 2.9 (1.2–4.7) |
14 | 2.8 (1.3–4.2) |
S | 1.4 (0.2–2.6) |
9 | 1.9 (0.6–3.1) |
| Mature B-cell lymphomas (except Burkitt lymphomas) | 6 | 1.6 (0.3–2.9) |
17 | 3.4 (1.8–4.9) |
S | 1.4 (0.2–2.6) |
13 | 2.7 (1.2–4.2) |
| Mature T-cell and NK-cell lymphomas | 6 | 1.6 (0.3–2.9) |
8 | 1.6 (0.5–2.7) |
S | 1.4 (0.2–2.6) |
S | 1.0 (0.1–1.9) |
| Non-Hodgkin lymphomas, NOS | S | 1.1 (0.0–2.1) |
8 | 1.6 (0.5–2.7) |
S | 0.6 (0.0–1.3) |
S | 0.6 (0.0–1.3) |
| Burkitt lymphoma/leukemia | 13 | 3.5 (1.9–5.4) |
16 | 3.2 (1.6–4.7) |
6 | 0.7 (0.3–3.0) |
7 | 1.5 (0.4–2.5) |
| Unspecified lymphomas | 0 | S | 0.6 (0.0–1.3) |
|||||
N; number of case; NOS, not otherwise specified; S, suppressed for any values under 6.